Zelira Therapeutics (AU:ZLD) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Zelira Therapeutics announced that all resolutions were successfully passed at their recent Annual General Meeting, showcasing strong shareholder support. The resolutions included key decisions such as the re-election of directors and the approval of a 10% placement capacity. This outcome reflects a positive sentiment towards the company’s strategic direction and governance.
For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.
